EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Spectrum of ocular adverse events associated with first-generation EGFR tyrosine kinase inhibitors: real-world experience and a proposed management algorithm from a tertiary cancer centre in India

Hridya Hareendran, Abhilash Menon iD, Praveen Kumar Shenoy, Nandini Devi Rajan, Shoaib Nawaz, M P Arun Krishnan

International Ophthalmology · 28.10.2026 · 46 (1)

DOI: 10.1007/s10792-026-04321-2 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift International Ophthalmology, online erschienen am 28.10.2026. Verfasst von Hridya Hareendran und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Ocular Oncology, Department of Surgical Oncology, Malabar Cancer Centre (Post Graduate Institute of Oncology Sciences & Research), Thalas…. Hauptthemen laut MEDLINE: Protein Kinase Inhibitors, Eye Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Kinase InhibitorsEye DiseasesHumansFemaleMaleRetrospective StudiesAgedIndiaErbB ReceptorsMiddle AgedTertiary Care CentersAdultCarcinoma, Non-Small-Cell LungErlotinib HydrochlorideLung NeoplasmsIncidenceAlgorithmsAged, 80 and overGefitinibAntineoplastic AgentsHead and Neck NeoplasmsTyrosine Kinase Inhibitors

Stichwörter der Autor:innen

EGFR-TKIEpidermal growth factor receptor tyrosine kinase inhibitorsErlotinibGefitinibOcular surface diseaseOcular toxicityTrichomegaly, blepharitis

Substanzen

Protein Kinase InhibitorsErbB ReceptorsErlotinib HydrochlorideEGFR protein, humanGefitinibAntineoplastic AgentsTyrosine Kinase Inhibitors

Autor:innen und Institutionen

  • Division of Ocular Oncology, Department of Surgical Oncology, Malabar Cancer Centre (Post Graduate Institute of Oncology Sciences & Research), Thalassery, Kerala, India.
  • Department of Clinical Hematology and Medical Oncology, Malabar Cancer Centre (Post Graduate Institute of Oncology Sciences & Research), Thalassery, Kerala, India. menonabhilash18@gmail.com.
  • Department of Clinical Hematology and Medical Oncology, Malabar Cancer Centre (Post Graduate Institute of Oncology Sciences & Research), Thalassery, Kerala, India.

ORCID-Profile: Abhilash Menon

Zitieren

APA

Hareendran, H., Menon, A., Shenoy, P. K., Rajan, N. D., Shoaib Nawaz, & Krishnan, M. P. A. (2026). Spectrum of ocular adverse events associated with first-generation EGFR tyrosine kinase inhibitors: real-world experience and a proposed management algorithm from a tertiary cancer centre in India. International Ophthalmology, 46(1). https://doi.org/10.1007/s10792-026-04321-2

Vancouver

Hareendran H, Menon A, Shenoy PK, Rajan ND, Shoaib Nawaz, Krishnan MPA. Spectrum of ocular adverse events associated with first-generation EGFR tyrosine kinase inhibitors: real-world experience and a proposed management algorithm from a tertiary cancer centre in India. International Ophthalmology. 2026;46(1). doi:10.1007/s10792-026-04321-2

BibTeX
@article{Hareendran2026,
  author = {Hareendran, Hridya and Menon, Abhilash and Shenoy, Praveen Kumar and Rajan, Nandini Devi and Shoaib Nawaz and Krishnan, M P Arun},
  title = {Spectrum of ocular adverse events associated with first-generation EGFR tyrosine kinase inhibitors: real-world experience and a proposed management algorithm from a tertiary cancer centre in India},
  journal = {International Ophthalmology},
  year = {2026},
  volume = {46},
  number = {1},
  doi = {10.1007/s10792-026-04321-2}
}
Kostenlos starten →